The administration of flurbiprofen during thoracoscopic radical surgery for lung cancer (53) can attenuate the levels of programmed cell death protein 1 (PD-1), an important immune checkpoint molecule, on CD8+ T cells within 72 hours postoperatively. The gene discussed is PDCD1; the disease is lung cancer.